fah hospital policy blog

Perspectives on health policy affecting America’s hospitals and the patients we serve.

Category Archives: medicare

FAH Leader Expresses Opposition to Ruling that Overturns 340B Medicare Regulation

January 02, 2019 | Chip Kahn

Category: Financing, Medicare, Pharmaceuticals

The DC Federal District Court’s ruling to stop reforms to Medicare payment for drugs acquired under the 340B drug discount program is unfortunate because it undermines HHS efforts to cut drug costs and promote fairer payments.

Read More »

FAH Submits Comments in Response to MA Proposed Rule

December 21, 2018 | FAH Policy Blog Team

Category: Medicare

Today, FAH submitted comments in response to a Proposed Rule from the Centers for Medicare & Medicaid Services (CMS) making changes to the Medicare Advantage (MA) program. The FAH letter addressed support for the following policies:

Read More »

Groups Urge Congress to Protect Seniors from Rising Drug Prices

November 13, 2018 | FAH Policy Blog Team

Category: Medicare, Pharmaceuticals

The Federation of American Hospitals joined 16 other groups in sending a letter to Congressional leaders today urging them to preserve the actions taken in the Bipartisan Budget Act (BBA) of 2018 to protect seniors and taxpayers from out-of-control drug prices during the upcoming lame duck session of Congress.

Read More »

FAH Leader Comments on the Trump Administration’s Proposal To Change Medicare Drug Prices

October 25, 2018 | Chip Kahn

Category: Financing, Medicare, Pharmaceuticals

We agree with the President that it is time to reduce the drug tab for Americans, but actions need to be focused on the real culprit - manufacturers’ prices - not the frontline hospitals and physicians who administer and prescribe those medicines. We look forward to examining the details and fine print of the Administration’s proposals.

Read More »